1Hengstman GJ, van Engelen BG, Vree Egberts WT, et al. Myositis-speeific autoantibodies:overview and recent develop ments[J]. Curr Opin Rheumatol, 2001,13 : 476-482.
2Hoogendijk JE, Amato AA, Lecky BR, et al. 119th ENMC international workshop; trial design in adult idiopathic inflam matory myopathies,with the exception of inclusion body myo- sitis, 10-12 October 2003 Naarden, The Netherlands[J]. Neu- romuscul Disord, 2004,14(5) :337- 345.
3Dalakas MC, Hohlfeld R. Polymyositis and dermato myositis [J]. Lancet, 2003, 362: 971-982.
4Englund PWJ, Fathi M, Rasmussen E, et al. Restricted TCR BV gene usage in lungs and muscle tissue of patients with idio- pathic inflammatory myopathies[J]. Arthrithis Rheum, 2007, 56: 372-383.
5Agrawal P, Ogilvy-Stuart A, Lees C. Intrauterine diagnosis and management of congenital goitrous hypothyroidism[J]. Ultrasound Obstet Gyneeol, 2002, 19(5): 501-505.
6Targoff IN. Update on myositis specific and myositis associat ed autoantibodies[J]. Curropin Rheumatol, 2000, 12 (6) : 475- 481.
